CAMBRIDGE, Mass., Oct. 30, 2007 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Steven H. Holtzman, Chair and Chief Executive Officer, will be presenting a company overview at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference being held November 5-7, 2007 in New York. Infinity’s presentation will take place on Tuesday, November 6, 2007, at 2:20 p.m. EST.
